ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borm, P.J.A.
Right arrow Articles by Schins, R.P.F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borm, P.J.A.
Right arrow Articles by Schins, R.P.F.
Eur Respir J 2001; 18:127S-133S
Copyright ©ERS Journals Ltd 2001


Genotype and phenotype in susceptibility to coal workers' pneumoconiosis. The use of cytokines in perspective

P.J.A. Borm and R.P.F. Schins

Dept of Fiber and Particle Toxicology, Medical Institute for Environmental Hygiene, University of Düsseldorf, Düsseldorf, Germany

CORRESPONDENCE: P.J.A. Borm, Medical Institute for Environmental Hygiene, Dept of Fiber and Particle Toxicology, PO Box 103571, D-40028, Düsseldorf, Germany. Fax: 49 2113389331

Keywords: biomarkers, coal workers' pneumoconiosis, cytokines, genotype, phenotype

Received: March 8, 2001
This work was supported by several grants including ECSC grant 7263/03.

The readily available technique of screening for gene polymorphisms could be used to explain inter-individual variability in a classic occupational interstitial lung disease, such as coal workers' pneumoconiosis (CWP).

The objective of this paper is to describe candidate genes selected from the wide pool of cytokines and growth factors, and to discuss the applications and pitfalls when using them as biomarkers for susceptibility to CWP. The selection of candidate genes is mainly based on observed phenotypic changes in bronchoalveolar lavage (BAL) fluid or BAL cells of patients with CWP, or on animal experiments that use quartz as the fibrogenic agent.

This paper also reviews the studies that have been performed to validate tumour necrosis factor genotype and phenotype with respect to CWP.

Finally, it is proposed that a multiple marker approach to susceptibility to CWP should be used. This involves the measurement of two cytokines (tumour necrosis factor and transforming growth factor-ß) to improve denomination of high- and low-risk groups.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the European Respiratory Society.